SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today introduced Helios TM, a CyTOF ® platform that enables system-level biology at single-cell resolution, on an ...
Fluidigm Corporation (NASDAQ:FLDM) today introduced HeliosTM, a CyTOF® platform that enables system-level biology at single-cell resolution, on an accessible, expandable system designed for ...
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2019 (GLOBE NEWSWIRE) -- The Human Proteome Organization (HUPO), an international scientific organization that promotes proteomics through international ...
SOUTH SAN FRANCISCO, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health ...
Industry-Leading CyTOF Technology Recognized at the 18th Annual HUPO World Congress for Delivering Unprecedented Proteomic Insight at Single-Cell Resolution SOUTH SAN FRANCISCO, Calif., Sept. 18, 2019 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results